SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-123646
Filing Date
2020-11-10
Accepted
2020-11-10 17:00:35
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029564-1_10q.htm 10-Q 633666
2 EXHIBIT 10.1 tm2029564d1_ex10-1.htm EX-10.1 13270
3 EXHIBIT 31.1 tm2029564d1_ex31-1.htm EX-31.1 11319
4 EXHIBIT 32.1 tm2029564d1_ex32-1.htm EX-32.1 4793
11 GRAPHIC tm2029564-1_10qimg001.jpg GRAPHIC 54185
  Complete submission text file 0001104659-20-123646.txt   4487483

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT syn-20200930.xml EX-101.INS 1068478
6 XBRL TAXONOMY EXTENSION SCHEMA syn-20200930.xsd EX-101.SCH 36903
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20200930_cal.xml EX-101.CAL 37299
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20200930_def.xml EX-101.DEF 151220
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20200930_lab.xml EX-101.LAB 297733
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20200930_pre.xml EX-101.PRE 262615
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 201301959
SIC: 2834 Pharmaceutical Preparations